Changes from COVID-19. A perspective from internal pediatric medicine

Pedro J Alcalá Minagorre1, Enrique Villalobos Pinto2, José Miguel Ramos Fernández3

  • 1Unidad de Hospitalización Pediátrica, Hospital General Universitario de Alicante, Alicante, Spain.

Anales De Pediatria
|October 19, 2020
PubMed

Insights

The COVID-19 pandemic significantly impacted pediatric hospital care, necessitating proactive strategies for readiness and operability. This review offers resources for pediatric hospital medicine practitioners facing future epidemic challenges.

Area of Science:

  • Pediatric Hospital Medicine
  • Infectious Disease Epidemiology
  • Healthcare Management

Background:

  • The SARS-CoV-2 (COVID-19) pandemic profoundly disrupted hospital pediatric medicine services.
  • Existing healthcare models required adaptation to manage new challenges posed by the pandemic.
  • Hospital internal pediatrics is crucial for integrated care of hospitalized children.

Purpose of the Study:

  • To analyze the impact of the SARS-CoV-2 epidemic on pediatric care.
  • To explore strategies for pediatric hospital readiness and operability during epidemics.
  • To review challenges and opportunities in pediatric hospital medicine during and after the pandemic.

Main Methods:

  • This is a review article analyzing the effects of the COVID-19 pandemic on pediatric hospital medicine.
  • It synthesizes existing scientific knowledge and best practices.
  • The review considers perspectives on future outbreaks and coexistence with other viral infections.

Main Results:

  • The pandemic necessitated significant changes in hospital pediatric units.
  • It highlighted the need for preparedness for future epidemics and potential integration with adult care.
  • Assistance for chronically ill children, safety, teaching, and ethical considerations were reviewed.

Conclusions:

  • Hospital pediatric medicine requires proactive measures and adaptation for epidemic preparedness.
  • Internal pediatric medicine practitioners need resources to navigate future challenges in hospitalization units.
  • The review provides a framework for enhancing pediatric care models in crisis situations.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
127
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
138
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
105
Transmission-based Precautions I: Contact, Enteric, and Droplets01:17

Transmission-based Precautions I: Contact, Enteric, and Droplets

Transmission-based precautions are for patients known to be infected or suspected to be infected or colonized with organisms that pose a significant risk to others. Some transmission-based precautions include contact, enteric, and droplet.
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
4.3K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
159
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.7K